Navigation Links
UA engineering professor Shane Snyder to speak in Korea on international water quality
Date:9/13/2012

TUCSON, Ariz. (Sept. 13, 2012) -- Shane Snyder, who earlier this year won best paper honors from the American Water Works Association (AWWA), has been invited to present in Korea this month to an expected audience of 3,500 at the 2012 International Water Association's (IWA) World Water Congress.

The University of Arizona environmental engineering professor's presentation will focus not only on his research addressing the reduction of certain emerging contaminants in drinking water -- the topic of his award-winning paper -- but also it will draw on his personal knowledge of global water quality issues. Snyder has traveled throughout the southwestern United States, India, China, and southeast Asia, including Singapore and Vietnam, studying water quality issues.

"How are these countries coping with the most fundamental of water safety questions: If you have one dollar to spend, where do you put it?" Snyder said. "In terms of public health, do you eradicate the last trace of caffeine in your drinking water, or do you build wells?"

Snyder is scheduled to meet with Korea's Minister of the Environment Sept. 19 then give his IWA presentation Sept. 20 during the closing keynote in Busan, Korea. The topic is emerging contaminants in drinking water and the different treatment levels required around the world to deliver safe water. He will co-present with Hansruedi Seigrist, head of environmental engineering at the Swiss Federal Institute of Aquatic Science and Technology.

Snyder's award-winning technical paper, "Perchlorate, Bromate and Chlorate in Hypochlorite Solutions: Guidelines for Utilities," is based on research that establishes new chlorine handling and on-site chlorine production best practices. The guidelines are expected to help minimize the levels of perchlorate and related contaminants commonly found in drinking water.

"The authors provide practical recommendations to utilities attempting to control production of these regulated contaminants when using sodium hypochlorite (chlorine) as a disinfectant," said Journal AWWA in a statement about the winning paper. The award was presented in June at AWWA's 2012 national convention in San Antonio.

Perchlorate, a byproduct of chlorine, can form in chlorine during production and storage by public water utilities that use it to disinfect drinking water. The U.S. Environmental Protection Agency considers it a contaminant of emerging concern because of its increasing presence in municipal water sources across the country. Chlorine quality and handling greatly influence the amount of perchlorate and related chemicals introduced into drinking water during the treatment process.

This is the first best paper award for Snyder, who is the co-director of the Arizona Laboratory for Emerging Contaminants and the director of the Snyder Research Group, which has laboratories at the UA's BIO5 Institute and the Environmental Research Laboratory.


'/>"/>

Contact: Steve Delgado
sdelgado@engr.arizona.edu
520-621-2815
University of Arizona College of Engineering
Source:Eurekalert  

Related biology news :

1. Columbia Engineering and Penn researchers increase speed of single-molecule measurements
2. Melting glaciers, enough sand to bury London, and ancient ecosystem engineering
3. Innovative cell printing technologies hold promise for tissue engineering R&D
4. 5th Annual Advances in Biomolecular Engineering Symposium
5. Medical device, health professionals attend first national conference on value-driven engineering
6. NSF report detailing growth in graduate enrollment in science & engineering in the past decade
7. Investigation of American Oriental Bioengineering, Inc. by Securities Lawyers at Goldfarb LLP Law Firm for Potential Shareholder Claim
8. Oligonucleotide Delivery: Biology, Engineering and Development Conference
9. GEN reports on growth of tissue engineering revenues
10. Engineering technology reveals eating habits of giant dinosaurs
11. Genetic Engineering & Biotechnology News unveils Biotech Boulevard
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UA engineering professor Shane Snyder to speak in Korea on international water quality
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: